Ske

GlaxoSmithKline: Uk approved company COVID-19 drug Sotrovimab, preliminary data shows that it remains active against Omikron
According to Bloomberg reported on Dec. 2, a document shows that preclinical data suggest that the company's covid-19 drug Sotrovaimab is active in all variants of concern, including Aomil...
Grant Ske
12-02
The pharmaceutical giants have made a cruel statement that GlaxoSmithKline will develop AIDS drugs by 2030
Grant Ske
12-03
The UK Medicines and Medical Products Regulatory Agency has approved the GlaxoSmithKline antibody drug Sotrovaimab for COVID-19 treatment
Financial Associated Press, December 2, GlaxoSmithKline said that preclinical data show that the company's new crown drug Sotrovaimab is active against Omilon. UK Pharmaceuticals and Medical Products...
Grant Ske
12-02
Tests showed GlaxoSmithKline (GSK. US) and Vir(VIR. US) antibody drugs are effective against Omicron
Zhitong Finance APP learned that GSK (GSK. US) said today that the company is working with its U.S. partner VirBiotechnology (VIR....
Test Grant Ske
12-02
GlaxoSmithKline Single-Tablet, Dual-Drug HIV Treatment Drug Dovitol was included in the 2021 National Health Insurance Directory
News from the Central Broadcasting Network on December 3 today (3rd), the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalogue (2021)" released by the National Medical Security Bureau...
Grant Ske
12-03
GlaxoSmithKline said its COVID-19 antibody drug appears to still be effective against Opmikron
GlaxoSmithKline said Thursday that in early tests, its coronavirus antibody drug sotorovimab appears to remain effective against the new mutant strain, Olmikeron. The company...
Grant Ske
12-03
GlaxoSmithKline monolithic and dual-drug HIV treatment drug Doveto was included in the national medical insurance list
Interface News learned that on December 3, in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalogue (2021)" released by the National Medical Security Bureau, Glaxo ...
Grant Ske
12-03
GlaxoSmithKline Sotrovimab was approved in the UK for COVID-19 treatment
Beijing Business News (reporter Yao Qian) On December 2, GlaxoSmithKline said that preclinical data showed that the company's new crown drug Sotrovimab remained active against Omilon. It is reported that...
Grant Ske
12-02
Pfizer's head of vaccine research and development jumped to GlaxoSmithKline
The Wall Street Journal reported on November 30 that Pfizer's head of viral vaccine science will leave the pharmaceutical giant to join rival GlaxoSmithKline. At Pfizer and...
Grant Ske
12-01
Targeted therapy for eosinophilic disease! The European Union approves glaxoSmithKline for 3 new indications
Grant Ske
11-20
Vir Biotechnology(VIR. US) pre-market rise of more than 10%! with GSK US) will provide $1 billion in COVID-19 antibody drugs to the United States
Zhitong Finance APP learned that GSK (GSK. US) and VirBiotechnology (VIR. US) will provide value to the U.S. next month1...
Grant Ske
11-18
GlaxoSmithKline brought 6 major innovation plates to enter the Bo Covenant and opened the "New GSK" strategic layout in China
In the context of the covid-19 pandemic, healthcare has ranked among the world's most concerned industries. Thanks to the release of medical consumption demand and the guidance of policies to the medical system, China's great health...
Grant Ske
11-09
GlaxoSmithKline shingles vaccine is available in China for prevention in adults aged 50 years and older
On the afternoon of June 28, vaccine giant GlaxoSmithKline (GSK) announced that the herpes zoster vaccine Xinanlishi was officially launched in China for the prevention of shingles in adults aged 50 years and older. ...
Grant Ske
11-09
GlaxoSmithKline signed a memorandum of understanding with Baidu Health to explore digital innovation models for disease prevention
Grant Ske
11-09
GlaxoSmithKline brings cutting-edge innovation achievements to the "Covenant of Entering the Expo" to protect people's health in an all-round way
achievement Grant Ske
11-09
Interview with GlaxoSke Chishin: With core competitiveness, we will steadily develop the Chinese market
Grant Ske
11-09
Blockbuster drugs are frequently unveiled! GlaxoSmithKline brings the world's first targeted drug for lupus erythematosus, with a 5-year survival rate of 90%
Grant Ske
11-07
Barron: GSK, an active embrace of change US), it's time to buy
Zhitong Finance observed that although GlaxoSmithKline (GSK. US) has been a laggard among big pharma companies over the past decade, but the aggressive actions of investors and the health of its consumers...
Barron Grant Ske
11-07
Another covid-19 miracle drug coming? Latest results from the GlaxoSmithKline trial: 85% lower risk of death
Antibody therapy is effective, and there are new coronavirus antibody drugs or soon approved in the United States. Multinational pharmaceutical giant GlaxoSmithKline and American pharmaceutical unicorn VirBiotechnolog...
Grant Ske Kexin
11-07
Supreme People's Court: GlaxoSmithKline was fined 3 billion yuan, and all of them have been implemented
Severely punish commercial bribery, illegal business and other crimes in the field of food and drug circulation, conclude the commercial bribery case of GlaxoSmithKline in accordance with the law, and sentence the defendant unit to a fine of 3 billion yuan and implement it in place. ...
Grant Ske
11-07